Literature DB >> 24401467

Prostate cancer: summary of updated NICE guidance.

John Graham1, Peter Kirkbride, Kimberley Cann, Elise Hasler, Matthew Prettyjohns.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24401467     DOI: 10.1136/bmj.f7524

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  29 in total

1.  Diagnostic test accuracy study of 18F-sodium fluoride PET/CT, 99mTc-labelled diphosphonate SPECT/CT, and planar bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer.

Authors:  Randi F Fonager; Helle D Zacho; Niels C Langkilde; Joan Fledelius; June A Ejlersen; Christian Haarmark; Helle W Hendel; Mine Benedicte Lange; Mads R Jochumsen; Jesper C Mortensen; Lars J Petersen
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-11-01

2.  [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].

Authors:  C Kesch; J P Radtke; F Distler; S Boxler; T Klein; C Hüttenbrink; K Hees; W Roth; M Roethke; H P Schlemmer; M Hohenfellner; B A Hadaschik
Journal:  Urologe A       Date:  2016-08       Impact factor: 0.639

Review 3.  [MRI of the prostate].

Authors:  D Nörenberg; O Solyanik; B Schlenker; G Magistro; B Ertl-Wagner; D A Clevert; C Stief; M F Reiser; M D'Anastasi
Journal:  Urologe A       Date:  2017-05       Impact factor: 0.639

4.  PI-RADS version 2.1 scoring system is superior in detecting transition zone prostate cancer: a diagnostic study.

Authors:  Zhibing Wang; Wenlu Zhao; Junkang Shen; Zhen Jiang; Shuo Yang; Shuangxiu Tan; Yueyue Zhang
Journal:  Abdom Radiol (NY)       Date:  2020-09-09

5.  Investigating the ability of multiparametric MRI to exclude significant prostate cancer prior to transperineal biopsy.

Authors:  Eva M Serrao; Tristan Barrett; Karan Wadhwa; Deepak Parashar; Julia Frey; Brendan C Koo; Anne Y Warren; Andrew Doble; Christof Kastner; Ferdia A Gallagher
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

6.  Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional study.

Authors:  Narhari Timilshina; Veronique Ouellet; Shabbir M H Alibhai; Anne-Marie Mes-Masson; Nathalie Delvoye; Darrel Drachenberg; Antonio Finelli; Marie-Paule Jammal; Pierre Karakiewicz; Hélène Lapointe; Jean-Baptiste Lattouf; Kenny Lynch; Jean-Benoît Paradis; Paula Sitarik; Alan So; Fred Saad
Journal:  World J Urol       Date:  2016-07-22       Impact factor: 4.226

Review 7.  All change in the prostate cancer diagnostic pathway.

Authors:  Derek J Lomas; Hashim U Ahmed
Journal:  Nat Rev Clin Oncol       Date:  2020-02-28       Impact factor: 66.675

8.  DESNT: A Poor Prognosis Category of Human Prostate Cancer.

Authors:  Bogdan-Alexandru Luca; Daniel S Brewer; Dylan R Edwards; Sandra Edwards; Hayley C Whitaker; Sue Merson; Nening Dennis; Rosalin A Cooper; Steven Hazell; Anne Y Warren; Rosalind Eeles; Andy G Lynch; Helen Ross-Adams; Alastair D Lamb; David E Neal; Krishna Sethia; Robert D Mills; Richard Y Ball; Helen Curley; Jeremy Clark; Vincent Moulton; Colin S Cooper
Journal:  Eur Urol Focus       Date:  2017-03-06

9.  Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study.

Authors:  Renata Zelic; Daniela Zugna; Matteo Bottai; Ove Andrén; Jonna Fridfeldt; Jessica Carlsson; Sabina Davidsson; Valentina Fiano; Michelangelo Fiorentino; Francesca Giunchi; Chiara Grasso; Luca Lianas; Cecilia Mascia; Luca Molinaro; Gianluigi Zanetti; Lorenzo Richiardi; Andreas Pettersson; Olof Akre
Journal:  Am J Epidemiol       Date:  2019-06-01       Impact factor: 4.897

10.  Residential Exposure to Road and Railway Noise and Risk of Prostate Cancer: A Prospective Cohort Study.

Authors:  Nina Roswall; Kirsten T Eriksen; Dorrit Hjortebjerg; Steen S Jensen; Kim Overvad; Anne Tjønneland; Ole Raaschou-Nielsen; Mette Sørensen
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.